Amanda Young

NPI: 1982075735
Total Payments
$7,100
2024 Payments
$1,989
Companies
46
Transactions
395
Medicare Patients
784
Medicare Billing
$56,325

Payment Breakdown by Category

Food & Beverage$7,088 (99.8%)
Education$12.80 (0.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,088 394 99.8%
Education $12.80 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $863.74 57 $0 (2024)
Merck Sharp & Dohme LLC $607.61 34 $0 (2024)
PFIZER INC. $389.69 25 $0 (2024)
Seagen Inc. $379.13 24 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $352.80 15 $0 (2024)
Janssen Biotech, Inc. $348.78 19 $0 (2024)
E.R. Squibb & Sons, L.L.C. $313.11 21 $0 (2024)
Myriad Genetic Laboratories, Inc. $282.37 5 $0 (2023)
Incyte Corporation $263.41 13 $0 (2024)
Lilly USA, LLC $233.01 16 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,989 99 Novartis Pharmaceuticals Corporation ($295.78)
2023 $2,073 115 Novartis Pharmaceuticals Corporation ($332.29)
2022 $1,736 101 E.R. Squibb & Sons, L.L.C. ($175.62)
2021 $1,302 80 Novartis Pharmaceuticals Corporation ($131.66)

All Payment Transactions

395 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
12/20/2024 Kyowa Kirin, Inc. Poteligeo (Drug) Food and Beverage In-kind items and services $22.18 General
Category: Monoclonal Antibody
12/18/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $18.95 General
Category: Immunology
12/13/2024 Takeda Pharmaceuticals U.S.A., Inc. FRUZAQLA (Drug) Food and Beverage In-kind items and services $24.16 General
Category: ONCOLOGY
12/09/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $18.96 General
Category: Oncology
12/03/2024 PFIZER INC. INLYTA (Drug), PADCEV Food and Beverage In-kind items and services $18.14 General
Category: ONCOLOGY
11/26/2024 Incyte Corporation MONJUVI (Drug), PEMAZYRE Food and Beverage Cash or cash equivalent $23.88 General
Category: Oncology
11/19/2024 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage In-kind items and services $24.87 General
Category: Oncology
11/14/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $18.30 General
Category: Oncology
11/13/2024 ABBVIE INC. EPKINLY (Drug), IMBRUVICA Food and Beverage In-kind items and services $15.61 General
Category: ONCOLOGY
11/11/2024 PFIZER INC. XTANDI (Drug), TALZENNA, ORGOVYX Food and Beverage In-kind items and services $18.15 General
Category: ONCOLOGY
11/08/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $18.54 General
Category: Oncology
10/30/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $18.18 General
Category: HORMONE THERAPY
10/23/2024 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Food and Beverage In-kind items and services $27.87 General
Category: Oncology
10/21/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $10.34 General
Category: Oncology
10/15/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $19.49 General
Category: Oncology
10/14/2024 Takeda Pharmaceuticals U.S.A., Inc. NINLARO (Drug) Food and Beverage In-kind items and services $26.85 General
Category: ONCOLOGY
10/10/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $17.29 General
Category: Oncology
10/09/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $22.66 General
Category: Immunology
10/03/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $3.69 General
Category: Oncology
09/25/2024 ARRAY BIOPHARMA INC BRAFTOVI (Drug), MEKTOVI, TUKYSA Food and Beverage In-kind items and services $18.92 General
Category: ONCOLOGY
09/20/2024 PFIZER INC. PADCEV (Biological) Food and Beverage In-kind items and services $17.73 General
Category: Oncology
09/18/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $27.72 General
Category: ONCOLOGY
09/17/2024 Takeda Pharmaceuticals U.S.A., Inc. FRUZAQLA (Drug) Food and Beverage In-kind items and services $28.40 General
Category: ONCOLOGY
09/13/2024 Kyowa Kirin, Inc. Poteligeo (Drug) Food and Beverage In-kind items and services $17.61 General
Category: Monoclonal Antibody
09/11/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $16.84 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 134 156 $24,977 $9,028
2022 3 195 220 $34,069 $12,810
2021 4 250 343 $54,283 $22,421
2020 3 205 250 $31,804 $12,065
Total Patients
784
Total Services
969
Medicare Billing
$56,325
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 67 88 $13,640 $5,128 37.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 25 25 $6,650 $2,354 35.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 42 43 $4,687 $1,547 33.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 83 103 $15,965 $6,120 38.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 34 34 $9,044 $3,449 38.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 78 83 $9,060 $3,241 35.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 101 193 $28,907 $12,270 42.4%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 56 56 $14,623 $6,178 42.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 81 82 $8,362 $2,873 34.4%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 12 12 $2,391 $1,101 46.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 94 137 $17,399 $6,638 38.2%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 30 30 $7,350 $3,022 41.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 81 83 $7,055 $2,405 34.1%

About Amanda Young

Amanda Young is a Acute Care healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2015. The National Provider Identifier (NPI) number assigned to this provider is 1982075735.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Young has received a total of $7,100 in payments from pharmaceutical and medical device companies, with $1,989 received in 2024. These payments were reported across 395 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($7,088).

As a Medicare-enrolled provider, Young has provided services to 784 Medicare beneficiaries, totaling 969 services with total Medicare billing of $56,325. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Acute Care
  • Location Birmingham, AL
  • Active Since 10/19/2015
  • Last Updated 10/19/2015
  • Taxonomy Code 363LA2100X
  • Entity Type Individual
  • NPI Number 1982075735

Products in Payments

  • KEYTRUDA (Biological) $607.61
  • OPDIVO (Biological) $282.53
  • BRACANALYSIS CDX (Device) $241.85
  • IMBRUVICA (Drug) $229.62
  • PADCEV (Biological) $197.44
  • ICLUSIG (Drug) $195.77
  • SCEMBLIX (Drug) $194.11
  • Medline (Device) $168.99
  • VERZENIO (Drug) $150.32
  • ORGOVYX (Drug) $148.27
  • ADCETRIS (Biological) $145.25
  • LIBTAYO (Biological) $132.01
  • Lenvima (Drug) $126.93
  • KISQALI (Drug) $124.88
  • IMFINZI (Biological) $124.13
  • JAKAFI (Drug) $118.06
  • IBRANCE (Drug) $111.24
  • XTANDI (Drug) $109.88
  • TUKYSA (Drug) $107.75
  • Orserdu (Drug) $107.40

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Acute Care Doctors in Birmingham